Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy
Wake Up Narcolepsy Announces Tammy Anderson as Executive Director and Honors Founder Monica Gow’s Inspiring 16 Year Legacy
